Therapeutic Effect of Recombinant Human Growth Hormone (rhGH) on the Myopathy of Cystinosis
Clinical trial NCT02124070 · WITHDRAWN
Trial details
- NCT number
- NCT02124070
- Sponsor
- National Human Genome Research Institute (NHGRI)
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-26
- Primary completion
- 2015-11-06
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.